Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:51 UTC
Update Date2023-02-21 17:18:22 UTC
HMDB IDHMDB0014997
Secondary Accession Numbers
  • HMDB14997
Metabolite Identification
Common NamePenicillamine
DescriptionPenicillamine is only found in individuals that have used or taken this drug. It is the most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. [PubChem]Penicillamine is a chelating agent recommended for the removal of excess copper in patients with Wilson's disease. From in vitro studies which indicate that one atom of copper combines with two molecules of penicillamine. Penicillamine also reduces excess cystine excretion in cystinuria. This is done, at least in part, by disulfide interchange between penicillamine and cystine, resulting in formation of penicillamine-cysteine disulfide, a substance that is much more soluble than cystine and is excreted readily. Penicillamine interferes with the formation of cross-links between tropocollagen molecules and cleaves them when newly formed. The mechanism of action of penicillamine in rheumatoid arthritis is unknown although it appears to suppress disease activity. Unlike cytotoxic immunosuppressants, penicillamine markedly lowers IgM rheumatoid factor but produces no significant depression in absolute levels of serum immunoglobulins. Also unlike cytotoxic immunosuppressants which act on both, penicillamine in vitro depresses T-cell activity but not B-cell activity.
Structure
Data?1676999902
Synonyms
ValueSource
(+-)-PenicillamineChEBI
2-Amino-3-mercapto-3-methylbutyric acidChEBI
3,3-DimethylcysteineChEBI
beta-MercaptovalineChEBI
D,L-PenicillamineChEBI
DL-3-MercaptovalineChEBI
DL-beta-MercaptovalineChEBI
2-Amino-3-mercapto-3-methylbutyrateGenerator
b-MercaptovalineGenerator
Β-mercaptovalineGenerator
DL-b-MercaptovalineGenerator
DL-Β-mercaptovalineGenerator
beta,beta-DimethylcysteineHMDB, MeSH
beta-ThiovalineHMDB
D-MercaptovalineHMDB
D-PenamineHMDB
D-PenicilamineHMDB
D-PenicillamineHMDB, MeSH
D-PenicyllamineHMDB
DimethylcysteineHMDB, MeSH
L-PenicillamineHMDB
PenicillaminHMDB
PenicillaminaHMDB
PenicilllamineHMDB
D-3-MercaptovalineMeSH, HMDB
CuprenilMeSH, HMDB
D 3 MercaptovalineMeSH, HMDB
CuprimineMeSH, HMDB
Penicillaminate, copperMeSH, HMDB
D PenicillamineMeSH, HMDB
MetalcaptaseMeSH, HMDB
Copper penicillaminateMeSH, HMDB
MercaptovalineMeSH, HMDB
beta,beta DimethylcysteineMeSH, HMDB
Chemical FormulaC5H11NO2S
Average Molecular Weight149.211
Monoisotopic Molecular Weight149.051049291
IUPAC Name2-amino-3-methyl-3-sulfanylbutanoic acid
Traditional Name(+-)-penicillamine
CAS Registry Number52-67-5
SMILES
CC(C)(S)C(N)C(O)=O
InChI Identifier
InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)
InChI KeyVVNCNSJFMMFHPL-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentValine and derivatives
Alternative Parents
Substituents
  • Valine or derivatives
  • Alpha-amino acid
  • Branched fatty acid
  • Thia fatty acid
  • Methyl-branched fatty acid
  • Fatty acid
  • Fatty acyl
  • Amino acid
  • Alkylthiol
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Primary amine
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Primary aliphatic amine
  • Carbonyl group
  • Organic oxygen compound
  • Amine
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point198.5 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility4.65 g/LNot Available
LogP-1.9Not Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility4.65 g/LALOGPS
logP-1.7ALOGPS
logP-2.1ChemAxon
logS-1.5ALOGPS
pKa (Strongest Acidic)2.56ChemAxon
pKa (Strongest Basic)9.09ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area63.32 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity37.22 m³·mol⁻¹ChemAxon
Polarizability14.88 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+131.8731661259
DarkChem[M-H]-126.00231661259
DeepCCS[M+H]+131.26930932474
DeepCCS[M-H]-128.11230932474
DeepCCS[M-2H]-165.06230932474
DeepCCS[M+Na]+139.99330932474
AllCCS[M+H]+132.432859911
AllCCS[M+H-H2O]+128.532859911
AllCCS[M+NH4]+136.032859911
AllCCS[M+Na]+137.032859911
AllCCS[M-H]-131.832859911
AllCCS[M+Na-2H]-134.732859911
AllCCS[M+HCOO]-138.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PenicillamineCC(C)(S)C(N)C(O)=O2508.0Standard polar33892256
PenicillamineCC(C)(S)C(N)C(O)=O1245.9Standard non polar33892256
PenicillamineCC(C)(S)C(N)C(O)=O1474.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Penicillamine,1TMS,isomer #1CC(C)(S)C(N)C(=O)O[Si](C)(C)C1304.5Semi standard non polar33892256
Penicillamine,1TMS,isomer #2CC(C)(S[Si](C)(C)C)C(N)C(=O)O1491.2Semi standard non polar33892256
Penicillamine,1TMS,isomer #3CC(C)(S)C(N[Si](C)(C)C)C(=O)O1432.8Semi standard non polar33892256
Penicillamine,2TMS,isomer #1CC(C)(S[Si](C)(C)C)C(N)C(=O)O[Si](C)(C)C1491.7Semi standard non polar33892256
Penicillamine,2TMS,isomer #1CC(C)(S[Si](C)(C)C)C(N)C(=O)O[Si](C)(C)C1530.7Standard non polar33892256
Penicillamine,2TMS,isomer #1CC(C)(S[Si](C)(C)C)C(N)C(=O)O[Si](C)(C)C1943.1Standard polar33892256
Penicillamine,2TMS,isomer #2CC(C)(S)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C1429.4Semi standard non polar33892256
Penicillamine,2TMS,isomer #2CC(C)(S)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C1402.3Standard non polar33892256
Penicillamine,2TMS,isomer #2CC(C)(S)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C1629.1Standard polar33892256
Penicillamine,2TMS,isomer #3CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O1569.3Semi standard non polar33892256
Penicillamine,2TMS,isomer #3CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O1481.0Standard non polar33892256
Penicillamine,2TMS,isomer #3CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O1745.5Standard polar33892256
Penicillamine,2TMS,isomer #4CC(C)(S)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1574.1Semi standard non polar33892256
Penicillamine,2TMS,isomer #4CC(C)(S)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1485.7Standard non polar33892256
Penicillamine,2TMS,isomer #4CC(C)(S)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1743.3Standard polar33892256
Penicillamine,3TMS,isomer #1CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C1593.2Semi standard non polar33892256
Penicillamine,3TMS,isomer #1CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C1585.8Standard non polar33892256
Penicillamine,3TMS,isomer #1CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C1592.8Standard polar33892256
Penicillamine,3TMS,isomer #2CC(C)(S)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1591.5Semi standard non polar33892256
Penicillamine,3TMS,isomer #2CC(C)(S)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1598.1Standard non polar33892256
Penicillamine,3TMS,isomer #2CC(C)(S)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1707.8Standard polar33892256
Penicillamine,3TMS,isomer #3CC(C)(S[Si](C)(C)C)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1736.5Semi standard non polar33892256
Penicillamine,3TMS,isomer #3CC(C)(S[Si](C)(C)C)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1643.2Standard non polar33892256
Penicillamine,3TMS,isomer #3CC(C)(S[Si](C)(C)C)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1709.9Standard polar33892256
Penicillamine,4TMS,isomer #1CC(C)(S[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1767.1Semi standard non polar33892256
Penicillamine,4TMS,isomer #1CC(C)(S[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1739.3Standard non polar33892256
Penicillamine,4TMS,isomer #1CC(C)(S[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1576.6Standard polar33892256
Penicillamine,1TBDMS,isomer #1CC(C)(S)C(N)C(=O)O[Si](C)(C)C(C)(C)C1534.9Semi standard non polar33892256
Penicillamine,1TBDMS,isomer #2CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O1745.3Semi standard non polar33892256
Penicillamine,1TBDMS,isomer #3CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O1671.2Semi standard non polar33892256
Penicillamine,2TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O[Si](C)(C)C(C)(C)C1968.4Semi standard non polar33892256
Penicillamine,2TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O[Si](C)(C)C(C)(C)C2013.7Standard non polar33892256
Penicillamine,2TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O[Si](C)(C)C(C)(C)C2127.3Standard polar33892256
Penicillamine,2TBDMS,isomer #2CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C1847.5Semi standard non polar33892256
Penicillamine,2TBDMS,isomer #2CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C1877.0Standard non polar33892256
Penicillamine,2TBDMS,isomer #2CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C1939.2Standard polar33892256
Penicillamine,2TBDMS,isomer #3CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O2062.0Semi standard non polar33892256
Penicillamine,2TBDMS,isomer #3CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O1938.8Standard non polar33892256
Penicillamine,2TBDMS,isomer #3CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O1978.5Standard polar33892256
Penicillamine,2TBDMS,isomer #4CC(C)(S)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2015.7Semi standard non polar33892256
Penicillamine,2TBDMS,isomer #4CC(C)(S)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C1934.0Standard non polar33892256
Penicillamine,2TBDMS,isomer #4CC(C)(S)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C1967.3Standard polar33892256
Penicillamine,3TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2253.1Semi standard non polar33892256
Penicillamine,3TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2228.5Standard non polar33892256
Penicillamine,3TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2003.9Standard polar33892256
Penicillamine,3TBDMS,isomer #2CC(C)(S)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2244.1Semi standard non polar33892256
Penicillamine,3TBDMS,isomer #2CC(C)(S)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2266.6Standard non polar33892256
Penicillamine,3TBDMS,isomer #2CC(C)(S)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2054.0Standard polar33892256
Penicillamine,3TBDMS,isomer #3CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2407.5Semi standard non polar33892256
Penicillamine,3TBDMS,isomer #3CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2282.1Standard non polar33892256
Penicillamine,3TBDMS,isomer #3CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2051.5Standard polar33892256
Penicillamine,4TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2629.0Semi standard non polar33892256
Penicillamine,4TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2527.0Standard non polar33892256
Penicillamine,4TBDMS,isomer #1CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2064.9Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, Positivesplash10-00dl-9300000000-53220ef4bf765d5867dc2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (1 TMS) - 70eV, Positivesplash10-0fka-9500000000-e42c54b7496cbff2d7612017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Penicillamine GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 10V, Positive-QTOFsplash10-0udi-1900000000-5ce6ffc67f24493fa02a2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 20V, Positive-QTOFsplash10-0ufr-5900000000-ac76f8c72b23359169052017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 40V, Positive-QTOFsplash10-00di-9000000000-2211209d297edcae5f722017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 10V, Negative-QTOFsplash10-01ot-0900000000-9a13581ec86df368b0002017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 20V, Negative-QTOFsplash10-03dj-1900000000-4c84239071ebf03d19f92017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 40V, Negative-QTOFsplash10-0089-9100000000-13c27853348bf51a69c12017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 10V, Positive-QTOFsplash10-0uxr-2900000000-33459beee34fc2a2011b2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 20V, Positive-QTOFsplash10-0uk9-6900000000-960c6308ce3675c6c5072021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 40V, Positive-QTOFsplash10-004l-9000000000-488ef4ddf13c867f5d332021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 10V, Negative-QTOFsplash10-0002-0900000000-5bc8874919ea1e2a5fda2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 20V, Negative-QTOFsplash10-001i-9000000000-942ac689538269d6ca7b2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Penicillamine 40V, Negative-QTOFsplash10-001i-9000000000-942ac689538269d6ca7b2021-10-11Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum

IR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted IR SpectrumIR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-)2023-02-03FELIX labView Spectrum
Predicted IR SpectrumIR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+)2023-02-03FELIX labView Spectrum
Predicted IR SpectrumIR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+)2023-02-03FELIX labView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00859 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00859 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4565
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPenicillamine
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID50868
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Munro R, Capell HA: Penicillamine. Br J Rheumatol. 1997 Jan;36(1):104-9. [PubMed:9117147 ]
  2. Suarez-Almazor ME, Spooner C, Belseck E: Penicillamine for rheumatoid arthritis. Cochrane Database Syst Rev. 2000;(2):CD001460. [PubMed:10796440 ]
  3. Walshe JM: The story of penicillamine: a difficult birth. Mov Disord. 2003 Aug;18(8):853-9. [PubMed:12889074 ]
  4. WALSHE JM: Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487-95. [PubMed:13362281 ]
  5. Gong Y, Frederiksen SL, Gluud C: D-penicillamine for primary biliary cirrhosis. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004789. [PubMed:15495127 ]
  6. Duruelo J, Cuende E, Preciado E, Diaz de Otazu R, Vesga JC: [Microscopic polyangiitis in a patient with systemic sclerosis]. Reumatol Clin. 2005 Oct;1(3):177-9. doi: 10.1016/S1699-258X(05)72739-X. Epub 2008 Dec 20. [PubMed:21794259 ]
  7. Masson MJ, Teranishi M, Shenton JM, Uetrecht JP: Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat. J Immunotoxicol. 2004 Apr;1(2):79-93. doi: 10.1080/15476910490496258. [PubMed:18958641 ]

Transporters

General function:
Involved in transporter activity
Specific function:
Mediates the Na(+)-independent transport of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. May play an important role in the clearance of bile acids and organic anions from the liver
Gene Name:
SLCO1B1
Uniprot ID:
Q9Y6L6
Molecular weight:
76448.0
References
  1. Gui C, Hagenbuch B: Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1. Protein Sci. 2009 Nov;18(11):2298-306. doi: 10.1002/pro.240. [PubMed:19760661 ]